Haron Nabihah, Rajendran Senthilmani, Kallarakkal Thomas George, Zain Rosnah Binti, Ramanathan Anand, Abraham Mannil Thomas, Lau Shin Hin, Cheng Lai Choo, Chong Sherrie Mei Yee, Mohamed Azahar Farah Aliya, Mohamad Zaini Zuraiza, Chan Siew Wui, Goh Yet Ching, Lim Daniel, Khairi Juliana, Abidin Marzuki Zainal, Abdul Rahman Zainal Ariff, Liew Chee Sun, Fong Siew Chinn, Yang Yi-Hsin, Ismail Siti Mazlipah, Cheong Sok Ching
Cancer Research Malaysia, Selangor, Malaysia.
Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
Oral Dis. 2023 Mar;29(2):380-389. doi: 10.1111/odi.13892. Epub 2021 May 11.
To evaluate the accuracy of MeMoSA®, a mobile phone application to review images of oral lesions in identifying oral cancers and oral potentially malignant disorders requiring referral.
A prospective study of 355 participants, including 280 with oral lesions/variants was conducted. Adults aged ≥18 treated at tertiary referral centres were included. Images of the oral cavity were taken using MeMoSA®. The identification of the presence of lesion/variant and referral decision made using MeMoSA® were compared to clinical oral examination, using kappa statistics for intra-rater agreement. Sensitivity, specificity, concordance and F1 score were computed. Images were reviewed by an off-site specialist and inter-rater agreement was evaluated. Images from sequential clinical visits were compared to evaluate observable changes in the lesions.
Kappa values comparing MeMoSA® with clinical oral examination in detecting a lesion and referral decision was 0.604 and 0.892, respectively. Sensitivity and specificity for referral decision were 94.0% and 95.5%. Concordance and F1 score were 94.9% and 93.3%, respectively. Inter-rater agreement for a referral decision was 0.825. Progression or regression of lesions were systematically documented using MeMoSA®.
Referral decisions made through MeMoSA® is highly comparable to clinical examination demonstrating it is a reliable telemedicine tool to facilitate the identification of high-risk lesions for early management.
评估一款用于查看口腔病变图像的手机应用程序MeMoSA®在识别需要转诊的口腔癌和口腔潜在恶性疾病方面的准确性。
对355名参与者进行了一项前瞻性研究,其中包括280名患有口腔病变/变体的患者。纳入在三级转诊中心接受治疗的年龄≥18岁的成年人。使用MeMoSA®拍摄口腔图像。将使用MeMoSA®对病变/变体的识别及转诊决策与临床口腔检查结果进行比较,采用kappa统计量评估评分者内一致性。计算敏感性、特异性、一致性和F1分数。由一名非现场专家对图像进行评估,并评估评分者间的一致性。比较连续临床就诊的图像,以评估病变的可观察变化。
在检测病变和转诊决策方面,将MeMoSA®与临床口腔检查结果进行比较的kappa值分别为0.604和0.892。转诊决策的敏感性和特异性分别为94.0%和95.5%。一致性和F1分数分别为94.9%和93.3%。转诊决策的评分者间一致性为0.825。使用MeMoSA®系统记录了病变的进展或消退情况。
通过MeMoSA®做出的转诊决策与临床检查高度可比,表明它是一种可靠的远程医疗工具,有助于识别高危病变以便早期管理。